, Tracking Stock Market Picks
Enter Symbol:

down 37.60 %

CELL THERAPEUTICS (CTIC) upgraded to Buy with price target $4.50 by WallachBeth

Posted on: Tuesday,  Aug 5, 2014  12:00 AM ET by WallachBeth

WallachBeth rated Buy CELL THERAPEUTICS (NASDAQ: CTIC) on 08/05/2014, when the stock price was $2.42. Since
then, CELL THERAPEUTICS has lost 37.60% as of 01/07/2016's recent price of $1.51.
If you would have followed this WallachBeth's recommendation on CTIC, you would have lost 37.6% of your investment in 520 days.

Cell Therapeutic developing, acquiring and commercializing novel treatments for cancer. Our goal is to build a leading, vertically-integrated biopharmaceutical company with a diversified portfolio of oncology drugs and drug candidates. The company's research and in-licensing activities are concentrated on identifying new, less toxic and more effective ways to treat cancer. The company has received fast-track designation from the FDA for this indication and expect to receive priority review, which would expedite the FDA's review of our application.

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/5/2014 12:00 AM Buy
2.42 4.50
as of 10/17/2014
1 Week up  3.63 %
1 Month down  -18.27 %
3 Months down  -5.78 %
1 YTD down  -5.78 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/19/2014 8:25 AM Hold
3.95 4.50

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy